AUPA Biopharm Co., Ltd.is founded on April 1st in 2013. The predecessor of the AUPA plant is the Roche pharmaceuticals’ Hsinchu plant, and the AUPA plant has got the PIC/S GMP certification in the August of 2012. AUPA offers the CMO and CDMO services of products development, products manufacture, products package, products distribution and products marketing. We are aggressive in introducing the newest technologies, facilities, and software to develop the technical platform for the specific dosage forms to provide the higher quality products. Besides, we are leading in Taiwan to set up the GS1 serialization in 2016 to provide our business partners more complete and entire services of products logistics includes distributions and sales managements.

Headed by the parents company (Anxo Pharmaceutical Co., Ltd.) , AUPA devote ourselves to collaborate with TAXO Parmaceutical Co., Ltd. to expend the market to hospitals, clinics, and pharmacies in Taiwan. We have got about 160 drug permit licenses from TFDA since the corporation is found in 2003. AUPA holds the spirit of Assurance, Universal, Professional, and Attitude to serve our clients. We always insist to provide our clients the most diversified and instant services to meet the market demands.